You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LA-HNSCC

Showing 1 - 25 of 1,192
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Oct 26, 2023

Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)

Not yet recruiting
  • Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
  • Monalizumab
  • Cetuximab
  • (no location specified)
Jan 8, 2023

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

Active, not recruiting
  • Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Pembrolizumab
    • +3 more
    • Chapel Hill, North Carolina
    • +1 more
    Oct 25, 2022

    Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab Combined With Neoadjuvant Chemotherapy)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Nimotuzumab Combined With Neoadjuvant Chemotherapy
    • (no location specified)
    Jun 29, 2022

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (NBTXR3, Cetuximab, Radiation Therapy)

    Recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • Tampa, Florida
    • +17 more
    Mar 22, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Chongqing (Camrelizumab, Concurrent cisplatin chemo, Intensity-modulated

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Jan 16, 2022

    Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla (Ibrutinib 560mg PO daily (Imbruvica),

    Active, not recruiting
    • Head and Neck Cancer
    • Squamous Cell Carcinoma of the Head and Neck
    • Ibrutinib 560mg PO daily (Imbruvica)
    • +2 more
    • La Jolla, California
      UCSD Moores Cancer Center
    Jan 11, 2023

    HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)

    Active, not recruiting
    • HNSCC
    • Lorient, France
      Centre Hospitalier Bretagne Sud
    Mar 10, 2022

    HNSCC Trial in Worldwide (Eftilagimod alpha, Pembrolizumab)

    Recruiting
    • HNSCC
    • Birmingham, Alabama
    • +28 more
    Nov 29, 2022

    Head and Neck Squamous Cell Carcinoma Trial in France, Germany, Spain (Cisplatin, 5-Fluorouracile, Docetaxel)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • Avignon, France
    • +16 more
    Aug 22, 2022

    Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RM-1995, Pembrolizumab)

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • RM-1995
    • Pembrolizumab
    • Duarte, California
    • +5 more
    Apr 6, 2022

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (volrustomig)

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • Prescott Valley, Arizona
    • +71 more
    Nov 10, 2023

    Recurrent Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Stage IV Trial in Spain (Nivolumab + Paclitaxel, Cetuximab +

    Active, not recruiting
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • Head and Neck Cancer Stage IV
    • Nivolumab + Paclitaxel
    • Cetuximab + Paclitaxel
    • Santander, Cantabria, Spain
    • +20 more
    Aug 2, 2022

    Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

    Not yet recruiting
    • Head and Neck Neoplasms
    • TransCon TLR7/8 Agonist
    • +2 more
    • (no location specified)
    Aug 4, 2023

    Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,

    Not yet recruiting
    • Advanced Head and Neck Squamous Cell Carcinoma
    • +2 more
    • CyPep-1
    • Pembrolizumab 25 MG/ML [Keytruda]
    • Pittsburgh, Pennsylvania
    • +18 more
    Nov 21, 2022

    Premalignant Lesion, Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in France (Samples collection, Psychological and

    Terminated
    • Premalignant Lesion
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
    • Samples collection
    • +3 more
    • Annecy, France
    • +9 more
    Oct 6, 2020

    Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide

    Recruiting
    • Unresectable Head and Neck Squamous Cell Carcinoma
    • +2 more
    • BNT113
    • Pembrolizumab
    • Los Angeles, California
    • +79 more
    Jan 9, 2023

    Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,

    Recruiting
    • Malignant Solid Tumor
    • +5 more
    • GEN1042
    • +8 more
    • San Diego, California
    • +27 more
    Dec 24, 2022

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Xevinapant, Placebo)

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Feb 10, 2023

    Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (Ulevostinag, Pembrolizumab)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
    • Los Angeles, California
    • +33 more
    Oct 4, 2021

    Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,

    Active, not recruiting
    • Melanoma (Skin)
    • +3 more
    • CV8102
    • CV8102 + anti-PD-1 therapy
    • Graz, Austria
    • +21 more
    Nov 3, 2021

    Head and Neck Tumors Trial in Worldwide (biological, radiation, drug)

    Recruiting
    • Head and Neck Neoplasms
    • Pembrolizumab 200 mg
    • +4 more
    • La Jolla, California
    • +173 more
    Apr 7, 2022

    Thyroid Cancer, Squamous Cell Carcinoma Head Neck Cancer (HNSCC), HRAS Mutant Tumor Trial in Worldwide (Tipifarnib)

    Completed
    • Thyroid Cancer
    • +3 more
    • Los Angeles, California
    • +34 more
    May 12, 2021